| When to measure lipid profile after stroke? | |
| | |
MedLine Citation:
|
PMID: 15731554 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Although acute decreases in total cholesterol (TC) are well documented in myocardial infarction, previous stroke studies have produced conflicting results. The timing of lipid estimation in ischemic stroke is becoming important with recent trial results indicating the benefits of statins. We therefore aimed to determine the optimal time for lipid measurements after stroke. We hypothesized that TC would acutely decrease after stroke and return to baseline by 12 weeks. METHODS AND RESULTS: We performed a prospective, observational study of 50 patients (age 68.5 +/- 11.2 years) who presented with acute ischemic stroke. Of these, 22 (44%) were HMG-CoA reductase (statin) naïve, 15 (30%) had already been on statins and 13 (26%) were commenced on statins. Of the 50 patients, 38 (76%) completed 12 weeks of follow-up, 5 died, and 7 were lost to follow-up. Fasting lipid profile (TC, low-density lipoprotein, high-density lipoprotein, triglyceride) was measured <48 h, 4 weeks and 12 weeks following ictus. In patients who were statin naïve, there was a significant increase in TC at the week 12 evaluation. CONCLUSIONS: Cholesterol levels in acute stroke are an unreliable measure of lipid status. Initiation of statins should ideally be based on measurements taken 12 weeks after stroke. |
| | |
Authors:
|
Bernard Yan; Mark Parsons; Sharyn McKay; Donald Campbell; Bernard Infeld; Raymond Czajko; Stephen M Davis |
Related Documents
:
|
22129914 - Extracorporeal versus peritoneal ultrafiltration in diuretic-resistant congestive heart... 20690094 - The effect of early and intensive statin therapy on ventricular premature beat or non-s... 12059984 - Oestrogen receptor gene variation is a determinant of coronary reactivity in healthy yo... 11455844 - Coronary calcification and cardiac events after percutaneous intervention in dialysis p... 1946114 - Arrhythmias and acute myocardial infarction. 6627384 - Selective coronary arteriography: a clinical comparison of two contrast agents. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2005-02-22 |
Journal Detail:
|
Title: Cerebrovascular diseases (Basel, Switzerland) Volume: 19 ISSN: 1015-9770 ISO Abbreviation: Cerebrovasc. Dis. Publication Date: 2005 |
Date Detail:
|
Created Date: 2005-04-08 Completed Date: 2005-06-13 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 9100851 Medline TA: Cerebrovasc Dis Country: Switzerland |
Other Details:
|
Languages: eng Pagination: 234-8 Citation Subset: IM |
Copyright Information:
|
Copyright 2005 S. Karger AG, Basel. |
Affiliation:
|
Department of Neurology, Royal Melbourne Hospital, Melbourne, Australia. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acute Disease Aged Anticholesteremic Agents / therapeutic use Chemistry, Clinical / standards* Cholesterol / blood* Female Follow-Up Studies Humans Hyperlipidemias / blood, drug therapy Male Middle Aged Prospective Studies Reproducibility of Results Stroke / blood* Time Factors |
| Chemical | |
Reg. No./Substance:
|
0/Anticholesteremic Agents; 57-88-5/Cholesterol |
| Comments/Corrections | |
Comment In:
|
Cerebrovasc Dis. 2005;20(3):211
[PMID:
16103647
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Severe umbilical cord acidemia and neurological outcome in preterm and full-term neonates.
Next Document: Neurotrophic factor expression after focal brain ischemia preceded by different preconditioning stra...